IPH6101, NK-cell engager
What is IPH6101?
IPH6101 is the first trifunctional anti-CD123 NKp46/CD16 NK cell engager using Innate’s proprietary multispecific antibody format ANKET®.
IPH6101 has shown anti-tumor activity in pre-clinical models, including supporting pharmacokinetic/pharmacodynamic (PK/PD) and safety data in non-human primate studies, leading to its selection as a drug candidate for development.